These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26178768)

  • 1. Pulmonary delivery of antitubercular drugs using spray-dried lipid-polymer hybrid nanoparticles.
    Bhardwaj A; Mehta S; Yadav S; Singh SK; Grobler A; Goyal AK; Mehta A
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1544-55. PubMed ID: 26178768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
    Wang Y; Kho K; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs.
    Kaur R; Garg T; Das Gupta U; Gupta P; Rath G; Goyal AK
    Artif Cells Nanomed Biotechnol; 2016; 44(1):182-7. PubMed ID: 24992699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
    Garg T; Goyal AK; Rath G; Murthy RS
    Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spray freeze drying for dry powder inhalation of nanoparticles.
    Ali ME; Lamprecht A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid loaded core shell nanoparticles derived from PLGA-PEG-PLGA tri-block copolymers: in vitro and in vivo drug release.
    Gajendiran M; Gopi V; Elangovan V; Murali RV; Balasubramanian S
    Colloids Surf B Biointerfaces; 2013 Apr; 104():107-15. PubMed ID: 23298594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
    Rawal T; Parmar R; Tyagi RK; Butani S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery.
    Suares D; Prabhakar B
    Drug Dev Ind Pharm; 2017 Feb; 43(2):213-224. PubMed ID: 27593545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of ciprofloxacin nanocrystals within liposomes by spray drying for controlled release via inhalation.
    Khatib I; Tang P; Ruan J; Cipolla D; Dayton F; Blanchard JD; Chan HK
    Int J Pharm; 2020 Mar; 578():119045. PubMed ID: 31981702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis.
    Saraogi GK; Sharma B; Joshi B; Gupta P; Gupta UD; Jain NK; Agrawal GP
    J Drug Target; 2011 Apr; 19(3):219-27. PubMed ID: 20540651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
    Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
    Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis.
    Garg T; Rath G; Goyal AK
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):997-1001. PubMed ID: 25682840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy.
    Topal GR; Devrim B; Eryilmaz M; Bozkir A
    J Microencapsul; 2018 Sep; 35(6):533-547. PubMed ID: 30213209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
    Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
    Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
    Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment.
    Paul PK; Nakpheng T; Paliwal H; Prem Ananth K; Srichana T
    Int J Pharm; 2024 Jul; 660():124309. PubMed ID: 38848797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.